InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
0.00%
)
US TECH 100
19,172.36
(
0.02%
)
Dow Jones
38,589.16
(
0.00%
)
Brent Oil
82.48
(
0.43%
)
Bitcoin
65,539.86
(
-1.65%
)
Post# of 177
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 57

Tuesday, 08/24/2010 7:26:18 AM

Tuesday, August 24, 2010 7:26:18 AM

Post# of 177
6:52AM Pharmasset initiates Phase 2b clinical trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3 (VRUS) 24.75 : Co initiates Phase 2b clinical trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3. The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up